From blood taken from the patient, a medicine is obtained based on the therapeutic properties to treat chronic back pain caused by degenerative disc disease. According to statistics, between 60% and 85% of the population have suffered lower back pain or will suffer from it at some point in their lives. The majority of these patients suffer from degenerative disc disease, where the disc between the vertebrae deteriorates and becomes thinner, increasing pressure on the vertebrae.
A hospital in Estepona, Málaga, is now offering a personalized regenerative medicine treatment for chronic back pain using plasma rich in growth factors (PRGF). The orthopedic and trauma surgeon, Javier Guerrero, from Hospiten Estepona, explained that this therapy aims to stimulate the regeneration of the affected intervertebral disc and relieve associated pain without the need for surgery.
The procedure involves extracting a sample of blood from the patient, processing it to concentrate the platelets and growth factors, and then injecting the concentrated solution into the affected intervertebral discs. This outpatient procedure is performed with the patient sedated and without general anesthesia. Three sessions of platelet-rich plasma are recommended for optimal results.
Chronic back pain can greatly reduce the quality of life for those who suffer from it, making daily activities difficult or impossible. By offering this innovative treatment, the Hospiten Estepona Spine unit aims to provide a revolutionary solution to a very common problem. After treatment, patients are advised to rest for approximately 24 hours before resuming normal activities.